Additionally, knockdown of METTL3 or METTL14 reduced the increased expression levels of CD133 and CTNNB1 triggered by IL-6 treatment, suggesting that the inflammatory response maintained the stem-like properties of CCA cells through modification of m6A modification (Figure 3E). The gene discussed is METTL14; the disease is cholangiocarcinoma.